EZH2 functional dichotomy in reactive oxygen species-stratified glioblastoma.
Saved in:
| Title: | EZH2 functional dichotomy in reactive oxygen species-stratified glioblastoma. |
|---|---|
| Authors: | Koh LWH; Neuro-Oncology Research Laboratory, Department of Research, National Neuroscience Institute, Singapore, Singapore., Pang QY; Neuro-Oncology Research Laboratory, Department of Research, National Neuroscience Institute, Singapore, Singapore., Novera W; Neuro-Oncology Research Laboratory, Department of Research, National Neuroscience Institute, Singapore, Singapore., Lim SW; Neuro-Oncology Research Laboratory, Department of Research, National Neuroscience Institute, Singapore, Singapore., Chong YK; Neuro-Oncology Research Laboratory, Department of Research, National Neuroscience Institute, Singapore, Singapore., Liu J; Laboratory of Single-Cell Spatial Neuromics, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Ang SYL; Department of Neurosurgery, National Neuroscience Institute, Singapore, Singapore.; SingHealth Duke-NUS Neuroscience Academic Clinical Programme, Duke-National University of Singapore Medical School, Singapore, Singapore., Loh RWY; Enabling Village, SG Enable, Singapore, Singapore., Shao H; Institute for Health Innovation & Technology, National University of Singapore, Singapore, Singapore.; Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore, Singapore.; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Ching J; Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore.; KK Research Centre, KK Women's and Children's Hospital, Singapore, Singapore., Wang Y; Singapore Phenome Centre, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore., Yip S; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, British Columbia, Canada., Tan P; Cancer and Stem Cell Biology Program, Duke-National University of Singapore Medical School, Singapore, Singapore.; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Li S; Cancer and Stem Cell Biology Program, Duke-National University of Singapore Medical School, Singapore, Singapore.; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Low DCY; Department of Neurosurgery, National Neuroscience Institute, Singapore, Singapore.; SingHealth Duke-NUS Neuroscience Academic Clinical Programme, Duke-National University of Singapore Medical School, Singapore, Singapore., Phelan A; BenevolentAI, London, UK., Rosser G; BenevolentAI, London, UK., Tan NS; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; School of Biological Sciences, Nanyang Technological University, Singapore, Singapore., Tang C; Neuro-Oncology Research Laboratory, Department of Research, National Neuroscience Institute, Singapore, Singapore.; Enabling Village, SG Enable, Singapore, Singapore.; Cancer and Stem Cell Biology Program, Duke-National University of Singapore Medical School, Singapore, Singapore., Ang BT; Neuro-Oncology Research Laboratory, Department of Research, National Neuroscience Institute, Singapore, Singapore.; Department of Neurosurgery, National Neuroscience Institute, Singapore, Singapore.; SingHealth Duke-NUS Neuroscience Academic Clinical Programme, Duke-National University of Singapore Medical School, Singapore, Singapore. |
| Source: | Neuro-oncology [Neuro Oncol] 2025 Feb 10; Vol. 27 (2), pp. 398-414. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-5866 |
|---|---|
| DOI: | 10.1093/neuonc/noae206 |
